HomeCompareDKSHF vs JEPI

DKSHF vs JEPI: Dividend Comparison 2026

DKSHF yields 3.81% · JEPI yields 8.56%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DKSHF wins by $17.5K in total portfolio value· pulled ahead in Year 3
10 years
DKSHF
DKSHF
● Live price
3.81%
Share price
$70.01
Annual div
$2.67
5Y div CAGR
23.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$46.8K
Annual income
$6,460.93
Full DKSHF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.56%
Share price
$55.65
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$1,573.67
Full JEPI calculator →

Portfolio growth — DKSHF vs JEPI

📍 DKSHF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDKSHFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DKSHF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DKSHF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DKSHF
Annual income on $10K today (after 15% tax)
$324.19/yr
After 10yr DRIP, annual income (after tax)
$5,491.79/yr
JEPI
Annual income on $10K today (after 15% tax)
$727.38/yr
After 10yr DRIP, annual income (after tax)
$1,337.62/yr
At 15% tax rate, DKSHF beats the other by $4,154.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DKSHF + JEPI for your $10,000?

DKSHF: 50%JEPI: 50%
100% JEPI50/50100% DKSHF
Portfolio after 10yr
$38.1K
Annual income
$4,017.30/yr
Blended yield
10.55%
📊

Analyst Conviction Gap

Where Wall Street is split right now

DKSHF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
5.8
Piotroski
7/9
JEPI
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DKSHF buys
0
JEPI buys
0
No recent congressional trades found for DKSHF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDKSHFJEPI
Forward yield3.81%8.56%
Annual dividend / share$2.67$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR23.5%0%
Portfolio after 10y$46.8K$29.3K
Annual income after 10y$6,460.93$1,573.67
Total dividends collected$22.9K$12.0K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: DKSHF vs JEPI ($10,000, DRIP)

YearDKSHF PortfolioDKSHF Income/yrJEPI PortfolioJEPI Income/yrGap
1$11,171$471.02$11,276$855.74$105.00JEPI
2$12,560$607.32$12,675$926.02$115.00JEPI
3← crossover$14,228$788.15$14,207$999.01+$21.00DKSHF
4$16,254$1,030.45$15,878$1,074.57+$376.00DKSHF
5$18,751$1,358.75$17,697$1,152.57+$1.1KDKSHF
6$21,872$1,809.15$19,674$1,232.87+$2.2KDKSHF
7$25,839$2,435.77$21,815$1,315.29+$4.0KDKSHF
8$30,969$3,321.26$24,131$1,399.68+$6.8KDKSHF
9$37,731$4,594.49$26,630$1,485.86+$11.1KDKSHF
10$46,834$6,460.93$29,323$1,573.67+$17.5KDKSHF

DKSHF vs JEPI: Complete Analysis 2026

DKSHFStock

DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, marketing, sales, distribution, and after-sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for ethical pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and fashion and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.

Full DKSHF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this DKSHF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DKSHF vs SCHDDKSHF vs ODKSHF vs KODKSHF vs MAINDKSHF vs JEPQDKSHF vs XYLDDKSHF vs DIVODKSHF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.